Bausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) Book value per share
Bausch + Lomb Corporation's book value per share at the end of fiscal 2025 was 18.4×, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was 18.2×. Over the past ten years it has ranged from 18.4× (fiscal 2025) to 28.5× (fiscal 2020) — the current reading is the lowest in ten years. Bausch + Lomb Corporation ranks 19th of 52 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 18.4× | (0.95%) |
| FY2024 | 18.6× | (5.78%) |
| FY2023 | 19.7× | (2.69%) |
| FY2022 | 20.3× | (24.47%) |
| FY2021 | 26.9× | (5.87%) |
| FY2020 | 28.5× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 18.2× | 0.88% |
| Jun 2026 | 18.0× | (0.66%) |
| Mar 2026 | 18.2× | (1.42%) |
| Dec 2025 | 18.4× | 0.41% |
| 20 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| TFX Teleflex Incorporated compare | 66.7× |
| ALGN Align Technology, Inc. compare | 60.6× |
| COO The Cooper Companies, Inc. compare | 43.2× |
| ATR AptarGroup, Inc. compare | 41.5× |
| RGEN Repligen Corporation compare | 37.0× |
| MMSI Merit Medical Systems, Inc. compare | 29.2× |
| BLCO Bausch + Lomb Corporation | 18.2× |
| MMED MiniMed Group, Inc. compare | 12.9× |
| AVTR Avantor, Inc. compare | 8.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on BLCO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement